|
Volumn 68, Issue 2, 1996, Pages 149-153
|
Disposition of rifampicin following intranasal and oral administration
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
RIFAMPICIN;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG POTENCY;
DRUG TISSUE LEVEL;
HUMAN;
HUMAN CELL;
HUMAN EXPERIMENT;
HUMAN TISSUE;
INTRANASAL DRUG ADMINISTRATION;
LEPROSY;
MALE;
MYCOBACTERIUM LEPRAE;
NORMAL HUMAN;
NOSE MUCUS;
ORAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
ADMINISTRATION, INTRANASAL;
ADMINISTRATION, ORAL;
ADULT;
CROSS-OVER STUDIES;
HUMANS;
LEPROSTATIC AGENTS;
LEPROSY;
MALE;
NASAL LAVAGE FLUID;
NASAL MUCOSA;
RIFAMPIN;
|
EID: 0030036937
PISSN: 02549395
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (9)
|